Table 2.

Applications of phage-based vaccines.

Condition	Agent	Target Antigen	Phage	Ref.
Viral infections	SARS-CoV-2	S protein, NP	Lambda, AP205, QβBxb1, Bxb2	[34,39,40,47,67,86,92]
	Influenza A virus	3M2e	T4	[38]
	Dengue virus	NS1	Qβ	[93]
	Foot-and-mouth disease	VP1	MS2, T7	[36,48]
	Zika virus	E protein	Qβ	[36]
Bacterial infections	Chlamydia trachomatis	CT584, MOMP	Qβ, MS2	[49,94]
	Escherichia coli	STh	AP205	[95]
	Vibrio Cholera	OSP	Qβ	[96]
	Bordetella pertussis	Pentasaccharide	Qβ	[97]
Parasite infections	Rhipicephalus microplus	Sbm746	M13	[41]
	Fasciola hepatic	Cathepsin	M13KE	[42,98]
	Plasmodium falciparum	Pfs47	AP205	[51]
Yeast infections	Candida albicans	Fba1	M13	[99]
Cancer	Breast cancer	HER2, xCT	Lambda, M13, MS2	[35,43,100,101]
	Leukemia	ASPH	SNS-301	[15]
	General	GD2	Qβ	[102]
	Metastasis and solid tumor	MUC1	Qβ	[103]
	Melanoma	Neoantigens	T7	[37]
Other conditions	Tauopathies	Tau	Qβ	[104]
	Hypertension	CaV1.2	Qβ	[46]
	Allergic rhinitis	H4R	M13	[105]
	Cardiovascular diseases	ApoB, PCSK9, and CETP	Qβ	[66]
	Fertility control	Gonadotropins	f8	[45]